MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2017 International Congress

    Assessments of Movement Disorder Symptoms and Functional Impacts in Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

    A. Bowden, S. Blair, K. Wesdock, M. Haller, M. Brandabur, P. Collins, A. Skrinar, J. Mayhew (Novato, CA, USA)

    Objective: To identify Clinical Outcome Assessments (COAs) appropriate for the evaluation of paroxysmal movement disorder symptoms and functional impact in Glut1 DS. Background: Glut1 DS…
  • 2017 International Congress

    Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS)

    S. Luo, G. Stebbins, Y. Liu, C. Goetz (Houston, TX, USA)

    Objective: Test if differential item functioning (DIF) due to gender, age, race/ethnicity or education level is present in UDysRS items.    Background: Testing a rating…
  • 2017 International Congress

    Using measurements from wearable sensors for automatic scoring of Parkinson’s disease motor states

    I. Thomas, F. Bergquist, R. Constantinescu, D. Nyholm, M. Senek, M. Memedi (Falun, Sweden)

    Objective: The aim of this study was to investigate the concurrent validity of an objective gait measure for assessment of motor states in advanced Parkinson’s…
  • 2017 International Congress

    The 3-step clinical prediction tool for falls in Parkinson’s disease: can it be used as a self-assessment measure?

    L. Mewburn, N. Allen, R. Adams, C. Canning (Lidcombe, Sydney, Australia)

    Objective: To determine if people with Parkinson’s disease (PD) are able to estimate their gait speed relative to a threshold speed of 1.1 m/s. Background:…
  • 2017 International Congress

    PDSS: A Novel Mobile-based Parkinson Disease Severity Score

    A. Zhan, S. Mohan, M. Elson, E. Dorsey, A. Terzis, S. Saria (Baltimore, MD, USA)

    Objective: To propose a novel mobile-based Parkinson Disease Severity Score (PDSS) to provide high resolution and objective severity monitoring for patients in the home setting.…
  • 2017 International Congress

    Physical Activity in Early Parkinson Disease

    S. Mantri, M. Fullard, J. Duda, J. Morley (Philadelphia, PA, USA)

    Objective: To characterize physical activity habits in patients with early Parkinson disease (PD). Background: Physical activity is an important therapy for PD as it may…
  • 2017 International Congress

    Autonomous Tracking of Body Bradykinesia during Unconstrained Activities in Parkinson’s Disease

    S. Roy, B. Shiwani, J. Kline, M. Saint-Hilaire, C. Thomas, M. Gennert, G. De Luca (Natick, MA, USA)

    Objective: To develop an algorithm for real-time automated detection of body bradykinesia during unconstrained activities using combined inertial measurement (IMU) and electromyographic (EMG) sensor data.…
  • 2017 International Congress

    Motor Heterogeneity in Parkinson’s Disease: A Bayesian Perspective

    A. Johnson, A. Loftus, N. Gasson, B. Lawrence, M. Thomas, R. Bucks (Perth, Australia)

    Objective: To identify motor symptom subtypes in idiopathic Parkinson’s disease (PD) using a Bayesian analytic approach to latent profile analysis. Background: Several subtypes of Parkinson’s…
  • 2016 International Congress

    Relationship between fatigue and sleep disturbances in patients with Parkinson’s disease: A study using Parkinson’s disease sleep scale-2

    K. Suzuki, A. Numao, T. Kadowaki, S. Suzuki, Y. Watanabe, M. Miyamoto, T. Miyamoto, T. Uchiyama, K. Hashimoto, H. Fujita, Y. Watanabe, T. Matsubara, K. Hirata (Mibu, Japan)

    Objective: To evaluate the relationship between fatigue and sleep disturbances in patients with Parkinson's disease (PD). Background: In patients with PD, fatigue is an important…
  • 2016 International Congress

    Comparison of Test Your Memory (TYM) and Montreal Cognitive Assessment (MoCA) measures in Parkinson’s disease

    E.J. Henderson, H. Chu, D.M. Gaunt, A.L. Whone, Y. Ben-Shlomo, V. Lyell (Bristol, United Kingdom)

    Objective: We sought to determine: a) the ability of TYM to discriminate between PD patients with and without cognitive deficits b) equivalence between MoCA scores…
  • « Previous Page
  • 1
  • …
  • 29
  • 30
  • 31
  • 32
  • 33
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley